Depo medrol

Phase 3Small molecule

BBrii Biosciences Limited

Depo medrol is one of 110 small molecule programs targeting Tendinitis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

109

Competitors

Pipeline

Status by Indication[3][1]

Indication

TendinitisActive, not recruiting

Postpartum DepressionActive, not recruiting

Back PainActive, not recruiting

Rheumatoid ArthritisActive, not recruiting

TendinitisPreclinical

Active, not recruiting

Postpartum DepressionPhase 2

Active, not recruiting

Back PainPreclinical

Active, not recruiting

Rheumatoid ArthritisPhase 3

Active, not recruiting

Competition

Competitive Landscape

791 competitors in Rheumatoid Arthritis

#DrugCompanyPhaseTrials

Depo medrol

BBrii Biosciences Limited

Phase 3

1 2

Rituxan

Roche

Preclinical

61 3

Orencia

Bristol-Myers Squibb

Preclinical

47 4

Cimzia

UCB

Preclinical

30 5

Simponi

Johnson & Johnson

Preclinical

19 6

Arcoxia

Novartis

Preclinical

4 7

Ilaris

Novartis

Preclinical

3 8

Zelhou

Jiangsu Simcere Pharmaceutical Co., Ltd.

Preclinical

7 9

Rituxan

Pfizer

Preclinical

7 10

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Post-ApprovalRecruiting

Study completion

NCT05929755

Clinical

Trials by Indication[1]

Rheumatoid Arthritis1 trial

The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis

Unknown status·AAttune Health Research, Inc.·Phase 3·NCT03511625·6 enrolled

Effectiveness1 trial

Effectiveness of Hydrolyzed Collagen Peptide Injection for the Treatment of Collateral Ligament Pain

Completed·TTiss'You srl·N/A·NCT05971004·62 enrolled

Tendinitis1 trial

Calcific Tendinitis: Comparing Minimally Invasive Modalities

Unknown status·LLakehead University·N/A·NCT02367560·60 enrolled

Back pain1 trial

Epidural Study of Patients With Chronic Lower Back Pain

Completed·HHamilton Health Sciences Corporation·N/A·NCT00887003·252 enrolled

Postpartum Depression1 trial

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

Completed·BBrii Biosciences Limited·Phase 2·NCT06057012·11 enrolled

1 more indication

Unspecified2 trials

Depo-Medrol on Psoas After LLIF

Recruiting·HHardeep Singh·Phase 4·NCT05929755·80 enrolled

Injection of Dorsal Scapular n at Different Levels, Dose it Make Difference?

Completed·—·Phase 2/3·NCT04693312·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Depo medrol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Depo medrol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Depo medrol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Brii Biosciences Limited company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: BBrii Biosciences Limited

Depo medrol

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Rheumatoid Arthritis1 trial

Effectiveness1 trial

Tendinitis1 trial

Back pain1 trial

Postpartum Depression1 trial

Unspecified2 trials

References

Drug Info

Quick Facts

Related News